LAST NEWS
11 June 2026
FY2025 Results
• Revenue up (+€28.0 million), driven by demand in the defense and rail sectors, as well as the integration of FDB Industries during the fiscal year; • EBITDA down to -€19.8 million,…
9 June 2026
Draw down of 600 bonds convertible into new shares for a nominal amount of 3 million euros
Read the press release (in French)
5 June 2026
Number of shares and voting rights as at 31/05/2026
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st May. Read the press release (in French)
27 May 2026
Extension of the negotiation period in connection with the proposed sale of the defense activities
Read the press release (in French)
12 May 2026
Number of shares and voting rights as at 30/04/2026
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th April. Read the press release (in French)
30 April 2026
Implementation of a new bond financing and postponement of the publication of the Group’s 2025 financial statements
Bond financing with a maximum nominal amount of €45 million over 36 months, in the form of OCBSA (bonds convertible into shares with warrants), implying potential dilution of more than 99%…
24 April 2026
Draw down of 400 bonds convertible into new shares for a nominal amount of 2 million euros
Read the press release (in French)
10 April 2026
Sale of its Defense activities: EUROPLASMA opens exclusive negotiations with a French investor
Read the press release (in French)